What are your thoughts on topical roflumilast as becoming standard of care and gradual shifting away from topical corticosteroids?
Featuring Peter Lio, MD |
Clinical Assistant Professor of Dermatology Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, IL
More from this series
Psoriasis
When augmenting oral and/or biologic therapy with a topical, what are some of the considerations you think through?
Featuring Peter Lio, MD
Psoriasis
What is the long-term safety and efficacy data of topical roflumilast?
Featuring Mark Lebwohl, MD
Psoriasis
How do you approach management of plaque psoriasis in challenging sensitive areas?
Featuring Peter Lio, MD
Related CME
1 Credit
Click to save this course
Psoriasis
CME
DermInsider - VGR Session 2
Mastering Psoriasis Management With Medicare
Release Date
March 27, 2025
1 Credit
Click to save this course
Psoriasis
CME
FC24: The Comorbidities of Psoriasis: What Clinicians Need to Know to Optimize Care: An Online Activity
Release Date
December 12, 2024
0.75 Credit
Click to save this course
Psoriasis
CME
FC24: Practical Insights and Pitfalls for Psoriatic Disease in Skin of Color: Early Diagnosis for Effective Treatment: An Online Activity
Release Date
December 12, 2024
Related Media
Powered by Polaris TM
Psoriasis
How has topical roflumilast simplified the way you consult patients with plaque psoriasis?Video
Peter A. Lio
Psoriasis
How have the emergence of nonsteroidal topical options in recent years impacted your practice?Video
Saakshi Khattri
Psoriasis
How do you foresee the availability of nonsteroidal topical options contributing to the standard of care for plaque psoriasis?Video
Jennifer Soung
Psoriasis
Can topical roflumilast replace topical corticosteroids, or are they meant to be used in tandem?Video
Raj Chovatiya